Trial · NCT03036150
Adverse events1,380
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,380
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Dapa 10 mg | 45 | 2,149 | 56 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 41 | 2,149 | 46 |
| other | Oedema peripheral | General disorders | Dapa 10 mg | 54 | 2,149 | 56 |
| other | Oedema peripheral | General disorders | Placebo | 63 | 2,149 | 75 |
| other | Nasopharyngitis | Infections and infestations | Dapa 10 mg | 92 | 2,149 | 136 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 81 | 2,149 | 118 |
| other | Urinary tract infection | Infections and infestations | Dapa 10 mg | 78 | 2,149 | 102 |
| other | Urinary tract infection | Infections and infestations | Placebo | 79 | 2,149 | 96 |
| other | Glomerular filtration rate decreased | Investigations | Dapa 10 mg | 39 | 2,149 | 45 |
| other | Glomerular filtration rate decreased | Investigations | Placebo | 61 | 2,149 | 67 |
| other | Hyperkalaemia | Metabolism and nutrition disorders | Dapa 10 mg | 53 | 2,149 | 67 |
| other | Hyperkalaemia | Metabolism and nutrition disorders | Placebo | 49 | 2,149 | 54 |
| other | Hypoglycaemia | Metabolism and nutrition disorders | Dapa 10 mg | 74 | 2,149 | 119 |
| other | Hypoglycaemia | Metabolism and nutrition disorders | Placebo | 70 | 2,149 | 96 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Dapa 10 mg | 44 | 2,149 | 46 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Placebo | 50 | 2,149 | 52 |
| other | Acute kidney injury | Renal and urinary disorders | Dapa 10 mg | 49 | 2,149 | 54 |
| other | Acute kidney injury | Renal and urinary disorders | Placebo | 44 | 2,149 | 50 |
| other | Renal impairment | Renal and urinary disorders | Dapa 10 mg | 51 | 2,149 | 55 |
| other | Renal impairment | Renal and urinary disorders | Placebo | 64 | 2,149 | 72 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03036150/events